Matt Dolan | DexCom, Inc. |
Kevin Ronald Sayer | DexCom, Inc. |
Steven Robert Pacelli | DexCom, Inc. |
Quentin Blackford | DexCom, Inc. |
David R. Lewis | Morgan Stanley & Co. LLC |
Jeffrey D. Johnson | Robert W. Baird & Co., Inc. |
Michael Weinstein | JPMorgan Securities LLC |
Jayson T. Bedford | Raymond James & Associates, Inc. |
Kyle William Rose | Canaccord Genuity, Inc. |
Doug Schenkel | Cowen & Co. LLC |
Danielle J. Antalffy | Leerink Partners LLC |
Margaret M. Kaczor | William Blair & Co. LLC |
J. P. McKim | Piper Jaffray & Co. |
Raj Denhoy | Jefferies LLC |
Joanne K. Wuensch | BMO Capital Markets (United States) |
Matthew Taylor | Barclays Capital, Inc. |
Tao L. Levy | Wedbush Securities, Inc. |
Suraj Kalia | Northland Securities, Inc. |
Chris Cooley | Stephens, Inc. |
Steven Lichtman | Oppenheimer & Co., Inc. |
Welcome to the DexCom third quarter 2017 earnings release conference call. My name is Adrien, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note this conference is being recorded.